PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsPropranolol
Inderide-40/25, Hemangiol(propranolol)
Hemangeol, Hemangiol, Inderal, Inderide, Inderide-, Innopran, Propranolol (propranolol) is a small molecule pharmaceutical. Propranolol was first approved as Inderide-40/25 on 1982-01-01. It is used to treat angina pectoris, esophageal and gastric varices, essential tremor, heart failure, and hypertension amongst others in the USA. It has been approved in Europe to treat hemangioma. The pharmaceutical is active against beta-1 adrenergic receptor, beta-2 adrenergic receptor, and beta-3 adrenergic receptor. In addition, it is known to target 5-hydroxytryptamine receptor 5A, hepatic sodium/bile acid cotransporter, and 5-hydroxytryptamine receptor 1A.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
neoplasmsD009369
digestive system diseasesD004066
nervous system diseasesD009422
cardiovascular diseasesD002318
signs and symptoms pathological conditionsD013568
mental disordersD001523
Trade Name
FDA
EMA
Hemangeol, Inderal, Innopran (generic drugs available since 1985-10-22)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Hydrochlorothiazide
+
Propranolol hydrochloride
Tradename
Company
Number
Date
Products
INDERIDE LA 80/50WyethN-019059 DISCN1985-07-03
1 products
INDERIDE LA 120/50WyethN-019059 DISCN1985-07-03
1 products
INDERIDE LA 160/50WyethN-019059 DISCN1985-07-03
1 products
INDERIDE-40/25WYETH PHARMS INCN-018031 DISCN1982-01-01
1 products, RLD
INDERIDE-80/25WYETH PHARMS INCN-018031 DISCN1982-01-01
1 products, RLD
Hide discontinued
Propranolol hydrochloride
Tradename
Company
Number
Date
Products
INDERAL LAANI PHARMSN-018553 RX1983-04-19
4 products, RLD
INNOPRAN XLANI PHARMSN-021438 RX2003-03-12
2 products, RLD, RS
HEMANGEOLLaboratoires Pierre FabreN-205410 RX2014-03-14
1 products, RLD, RS
Show 3 discontinued
Labels
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Propranolol Hydrochloride, Hemangeol, Pierre Fabre Derma
83384892028-10-16U-1496
89872622028-10-16U-1988
ATC Codes
C: Cardiovascular system drugs
C07: Beta-adrenergic blocking agents
C07A: Beta blocking agents
C07AA: Beta blocking agents, non-selective
C07AA05: Propranolol
C07B: Beta blocking agents and thiazides
C07BA: Beta blocking agents, non-selective, and thiazides
C07BA05: Propranolol and thiazides
C07F: Beta blocking agents, other combinations
C07FX: Beta blocking agents, other combinations
C07FX01: Propranolol and other combinations
HCPCS
Code
Description
J1800
Injection, propranolol hcl, up to 1 mg
Clinical
Clinical Trials
373 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Liver cirrhosisD008103EFO_0001422K74.01411101436
Post-traumatic stress disordersD013313EFO_0001358F43.141356328
Portal hypertensionD006975EFO_0000666K76.612621221
Esophageal and gastric varicesD004932EFO_0009545I85146516
Migraine disordersD008881EFO_0003821G43124411
HemangiomaD006391D18.01421411
Traumatic brain injuriesD000070642S0623138
Heart diseasesD006331EFO_0003777I51.9257
HypertensionD006973EFO_0000537I1011135
Postural orthostatic tachycardia syndromeD054972G90.A11125
Show 50 more
Indications Without Phase
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePropranolol
INNpropranolol
Description
Propranolol is a propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3. It has a role as a beta-adrenergic antagonist, an anxiolytic drug, an anti-arrhythmia drug, a vasodilator agent, an antihypertensive agent, a xenobiotic, an environmental contaminant and a human blood serum metabolite. It is a secondary amine, a propanolamine and a member of naphthalenes. It is functionally related to a 1-naphthol.
Classification
Small molecule
Drug classbeta-blockers (propranolol type)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC(C)NCC(O)COc1cccc2ccccc12
Identifiers
PDB
CAS-ID525-66-6
RxCUI
ChEMBL IDCHEMBL27
ChEBI ID8499
PubChem CID4946
DrugBankDB00571
UNII ID9Y8NXQ24VQ (ChemIDplus, GSRS)
Target
Agency Approved
ADRB1
ADRB1
ADRB2
ADRB2
ADRB3
ADRB3
Organism
Homo sapiens
Gene name
ADRB1
Gene synonyms
ADRB1R, B1AR
NCBI Gene ID
Protein name
beta-1 adrenergic receptor
Protein synonyms
adrenergic, beta-1-, receptor, Beta-1 adrenoceptor, Beta-1 adrenoreceptor
Uniprot ID
Mouse ortholog
Adrb1 (11554)
beta-1 adrenergic receptor (P34971)
Alternate
HTR5A
HTR5A
SLC10A1
SLC10A1
HTR1A
HTR1A
Organism
Homo sapiens
Gene name
HTR5A
Gene synonyms
NCBI Gene ID
Protein name
5-hydroxytryptamine receptor 5A
Protein synonyms
5-HT-5, 5-HT-5A, 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled, Serotonin receptor 5A
Uniprot ID
Mouse ortholog
Htr5a (15563)
5-hydroxytryptamine receptor 5A (Q3URB0)
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Propranolol
+
Hydrochlorothiazide
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Propranolol
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 39,969 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
14,000 adverse events reported
View more details
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use